Brief: Karolinska Development's Portfolio Company Presents Preclinical Results
June 23 (Reuters) - Karolinska Development AB KDEV.ST :
* KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY PROMIMIC
PRESENTS
PRECLINICAL RESULTS SHOWING DECREASED BACTERIAL ADHESION TO
IMPLANTS
* PRECLINICAL RESULTS SHOWING THAT COMPANY'S HA(NANO)
SURFACE
COATING TECHNOLOGY REDUCES RISK OF ADHESION BY COMMON PATHOGENIC
BACTERIA BY UP TO 60%
Source text for Eikon: ID:nGNEbHqsX4
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue